Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sex Workers | 13 | 2024 | 116 | 5.820 |
Why?
|
| Intimate Partner Violence | 2 | 2023 | 55 | 1.510 |
Why?
|
| Sex Work | 4 | 2021 | 39 | 1.420 |
Why?
|
| HIV Infections | 12 | 2023 | 5097 | 1.200 |
Why?
|
| Cross-Sectional Studies | 12 | 2023 | 1422 | 1.050 |
Why?
|
| Violence | 6 | 2023 | 68 | 0.920 |
Why?
|
| Rape | 1 | 2023 | 10 | 0.830 |
Why?
|
| Social Stigma | 2 | 2023 | 80 | 0.800 |
Why?
|
| Mental Health | 2 | 2021 | 91 | 0.730 |
Why?
|
| Female | 16 | 2023 | 9103 | 0.690 |
Why?
|
| South Africa | 15 | 2023 | 7596 | 0.650 |
Why?
|
| Depression | 2 | 2018 | 121 | 0.650 |
Why?
|
| Condoms | 2 | 2019 | 88 | 0.640 |
Why?
|
| Humans | 18 | 2024 | 14537 | 0.630 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 12 | 0.600 |
Why?
|
| Sexual Behavior | 3 | 2018 | 320 | 0.540 |
Why?
|
| Adult | 10 | 2022 | 5913 | 0.530 |
Why?
|
| Drug Resistance, Viral | 1 | 2017 | 278 | 0.500 |
Why?
|
| Parent-Child Relations | 1 | 2014 | 16 | 0.450 |
Why?
|
| Communication | 1 | 2014 | 57 | 0.430 |
Why?
|
| HIV-1 | 2 | 2022 | 1260 | 0.430 |
Why?
|
| Reproductive Health | 1 | 2014 | 51 | 0.430 |
Why?
|
| Middle Aged | 7 | 2021 | 3601 | 0.400 |
Why?
|
| Risk Factors | 4 | 2021 | 1475 | 0.370 |
Why?
|
| Adolescent | 7 | 2022 | 2985 | 0.360 |
Why?
|
| Pre-Exposure Prophylaxis | 2 | 2023 | 196 | 0.300 |
Why?
|
| Anti-HIV Agents | 3 | 2023 | 1324 | 0.280 |
Why?
|
| Prevalence | 3 | 2022 | 1192 | 0.260 |
Why?
|
| Morals | 1 | 2024 | 5 | 0.230 |
Why?
|
| Sex Offenses | 2 | 2022 | 29 | 0.220 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 51 | 0.220 |
Why?
|
| Incidence | 2 | 2023 | 685 | 0.220 |
Why?
|
| Global Health | 1 | 2024 | 193 | 0.210 |
Why?
|
| Peptic Ulcer | 1 | 2023 | 4 | 0.210 |
Why?
|
| Herpes Genitalis | 1 | 2023 | 43 | 0.200 |
Why?
|
| Male | 7 | 2021 | 6754 | 0.200 |
Why?
|
| Physical Abuse | 1 | 2022 | 8 | 0.190 |
Why?
|
| Biomarkers | 1 | 2022 | 327 | 0.180 |
Why?
|
| Circumcision, Male | 2 | 2019 | 99 | 0.180 |
Why?
|
| Employment | 1 | 2021 | 27 | 0.180 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 52 | 0.170 |
Why?
|
| HIV Seropositivity | 1 | 2022 | 265 | 0.160 |
Why?
|
| Anthropology, Cultural | 1 | 2019 | 5 | 0.160 |
Why?
|
| Young Adult | 4 | 2021 | 2498 | 0.160 |
Why?
|
| Safe Sex | 1 | 2019 | 68 | 0.150 |
Why?
|
| Interviews as Topic | 1 | 2019 | 203 | 0.150 |
Why?
|
| Counselors | 1 | 2018 | 6 | 0.150 |
Why?
|
| Adolescent Health Services | 1 | 2018 | 17 | 0.150 |
Why?
|
| AIDS Vaccines | 1 | 2019 | 152 | 0.140 |
Why?
|
| Educational Status | 1 | 2017 | 68 | 0.140 |
Why?
|
| Viremia | 1 | 2017 | 66 | 0.140 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2017 | 118 | 0.140 |
Why?
|
| Phylogeny | 1 | 2017 | 231 | 0.140 |
Why?
|
| Reproductive Health Services | 1 | 2018 | 66 | 0.140 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 106 | 0.130 |
Why?
|
| Age Factors | 1 | 2017 | 370 | 0.130 |
Why?
|
| Genotype | 1 | 2017 | 442 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 563 | 0.130 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 411 | 0.120 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 656 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 256 | 0.120 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 60 | 0.120 |
Why?
|
| Poverty | 1 | 2015 | 152 | 0.110 |
Why?
|
| Viral Load | 1 | 2017 | 819 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 171 | 0.110 |
Why?
|
| Health Promotion | 1 | 2014 | 109 | 0.110 |
Why?
|
| Sex Factors | 1 | 2014 | 227 | 0.110 |
Why?
|
| Logistic Models | 1 | 2014 | 254 | 0.110 |
Why?
|
| Counseling | 2 | 2018 | 143 | 0.060 |
Why?
|
| Ulcer | 1 | 2023 | 7 | 0.050 |
Why?
|
| Genitalia | 1 | 2023 | 8 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2023 | 43 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 253 | 0.050 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 29 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 365 | 0.040 |
Why?
|
| Models, Biological | 1 | 2021 | 77 | 0.040 |
Why?
|
| Pandemics | 1 | 2023 | 296 | 0.040 |
Why?
|
| Administration, Intravaginal | 1 | 2019 | 50 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 96 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2019 | 49 | 0.040 |
Why?
|
| Focus Groups | 1 | 2018 | 196 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 262 | 0.030 |
Why?
|
| Rwanda | 1 | 2014 | 30 | 0.030 |
Why?
|
| Zambia | 1 | 2014 | 115 | 0.030 |
Why?
|
| Kenya | 1 | 2014 | 183 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2015 | 215 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2014 | 187 | 0.030 |
Why?
|
| Mass Screening | 1 | 2014 | 245 | 0.030 |
Why?
|